Active Not RecruitingNCT04135846
Doxazosin and stress responses in alcohol use treatment research
About this title
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
Read the official source — NCT04135846Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- ProvidenceSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 19, 2019
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 184
- Sponsor
- Brown University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT04135846
- Official title
Show the full official title
A Focus on Alpha-1 Blockade as a Novel Pharmacological Treatment for AUD
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Providence
Questions about this study
Who is behind this study?
The study sponsor is Brown University, a university.
Does this study involve medication?
Yes. The study involves medication, including Doxazosin and Placebo.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
